Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2026 and 2025.


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2026		2025		2026		2025
Research and development	$	55	$	373	$	109	$	1,072
General and administrative		771		2,431		1,111		3,821
Total	$	826	$	2,804	$	1,220	$	4,893

The table above includes approximately $0.6 million and $0.7 million of compensation expense for the three and six months ended June 30, 2026 related to the Series D-2 and D-3 Preferred Stock issued in connection with the Ergatta Acquisition (see Note 23), and is reflected in General and administrative expense. For the three and six months ended June 30, 2025, the Company recognized stock-based compensation expense of $0.1 million and $0.5 million, respectively, was capitalized as software development costs. No stock-based compensation was capitalized during the three and six months ended June 30, 2026.

During the six months ended June 30, 2026, the Company did not grant any shares under the 2023 and 2020 Plans, and there were no stock options outstanding as of June 30, 2026 and December 31, 2025. The Company has not granted any restricted stock or stock appreciation rights.

As of June 30, 2026 and December 31, 2025, the Company had $0.2 million and $0.9 million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of 0.1 years and 0.2 years, respectively.